This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
E Andersson , B Ljotsson , E Hedman , V Kaldo , B Paxling , G Andersson , N Lindefors , C Ruck (2011). Internet-based cognitive behavior therapy for obsessive compulsive disorder: a pilot study. BMC Psychiatry 11, 125.
G Andersson (2009). Using the Internet to provide cognitive behaviour therapy. Behaviour Research and Therapy 47, 175–180.
L Baer , MA Blais (2010). Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Humana: New York.
DH Barlow (2010). Negative effects from psychological treatments: a perspective. American Psychologist 65, 13–20.
DT Braga , AV Cordioli , K Niederauer , GG Manfro (2005). Cognitive-behavioral group therapy for obsessive-compulsive disorder: a 1-year follow-up. Acta Psychiatrica Scandinavica 112, 180–186.
ME Coles , LM Cook , TR Blake (2007). Assessing obsessive compulsive symptoms and cognitions on the Internet: evidence for the comparability of paper and Internet administration. Behaviour Research and Therapy 45, 2232–2240.
HJ Eysenck (1963). Behaviour therapy, extinction and relapse in neurosis. British Journal of Psychiatry 109, 12–18.
EB Foa , JD Huppert , S Leiberg , R Langner , R Kichic , G Hajcak , PM Salkovskis (2002). The Obsessive-Compulsive Inventory: development and validation of a short version. Psychological Assessment 14, 485–496.
WK Goodman , LH Price , SA Rasmussen , C Mazure , RL Fleischmann , CL Hill , GR Heninger , DS Charney (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 46, 1006–1011.
SC Hayes (2004). Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies. Behavior Therapy 35, 639–665.
E Hedman , B Ljótsson , C Rück , T Furmark , P Carlbring , N Lindefors , G Andersson (2010). Internet administration of self-report measures commonly used in research on social anxiety disorder: a psychometric evaluation. Computers in Human Behavior 26, 736–740.
M Hennessy , GA Bolan , T Hoxworth , M Iatesta , F Rhodes , JM Zenilman (1999). Using growth curves to determine the timing of booster sessions. Structural Equation Modeling: A Multidisciplinary Journal 6, 322–342.
F Hollandare , G Andersson , I Engstrom (2010). A comparison of psychometric properties between internet and paper versions of two depression instruments (BDI-II and MADRS-S) administered to clinic patients. Journal of Medical Internet Research 12, e49.
NS Jacobson , P Truax (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12–19.
H Jonsson , E Hougaard , BE Bennedsen (2011). Randomized comparative study of group versus individual cognitive behavioural therapy for obsessive compulsive disorder. Acta Psychiatrica Scandinavica 123, 387–397.
P Lane (2008). Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharmaceutical Statistics 7, 93–106.
A Lazarov , R Dar , N Liberman , Y Oded (2012). Obsessive-compulsive tendencies and undermined confidence are related to reliance on proxies for internal states in a false feedback paradigm. Journal of Behavior Therapy and Experimental Psychiatry 43, 556–564.
A Lazarov , R Dar , Y Oded , N Liberman (2010). Are obsessive-compulsive tendencies related to reliance on external proxies for internal states? Evidence from biofeedback-aided relaxation studies. Behaviour Research and Therapy 48, 516–523.
CH Mallinckrodt , WS Clark , SR David (2001). Accounting for dropout bias using mixed-effects models. Journal of Biopharmaceutical Statistics 11, 9–21.
S Rachman , R Hodgson , IM Marks (1971). The treatment of chronic obsessive-compulsive neurosis. Behaviour Research and Therapy 9, 237–247.
M Rufer , I Hand , H Alsleben , A Braatz , J Ortmann , B Katenkamp , S Fricke , H Peter (2005). Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial. European Archives of Psychiatry and Clinical Neurosciences 255, 121–128.
HB Simpson , EB Foa , MR Liebowitz , DR Ledley , JD Huppert , S Cahill , D Vermes , AB Schmidt , E Hembree , M Franklin , R Campeas , CG Hahn , E Petkova (2008). A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry 165, 621–630.
HB Simpson , JD Huppert , E Petkova , EB Foa , MR Liebowitz (2006). Response versus remission in obsessive-compulsive disorder. Journal of Clinical Psychiatry 67, 269–276.
P Svanborg , M Åsberg (1994). A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatrica Scandinavica 89, 21–28.
P van Oppen , AJ van Balkom , E de Haan , R van Dyck (2005). Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. Journal of Clinical Psychiatry 66, 1415–1422.
MA Whisman (1990). The efficacy of booster maintenance sessions in behavior therapy: review and methodological critique. Clinical Psychology Review 10, 155–170.
ML Whittal , M Robichaud , DS Thordarson , PD McLean (2008). Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials. Journal of Consulting and Clinical Psychology 76, 1003–1014.
BM Wootton , BF Dear , L Johnston , MD Terides , N Titov (2013). Remote treatment of obsessive-compulsive disorder: a randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders 2, 375–384.
BM Wootton , N Titov , BF Dear , J Spence , G Andrews , L Johnston , K Solley (2011). An Internet administered treatment program for obsessive-compulsive disorder: a feasibility study. Journal of Anxiety Disorders 25, 1102–1107.